EGFR R521K Polymorphism is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer
Cancers(2022)
Key words
EGFR,head and neck cancer,cetuximab,drug resistance,R521K,antibody-dependent cellular cytotoxicity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined